Ohio Seniors Are Overlooking the Health Risks of Hearing Loss

A TruHearing survey of Ohio seniors finds 44% report experiencing hearing loss, but only 12% have sought treatment; 75% of untreated seniors say their hearing is “good enough” versus 66% nationally. It also shows 78% haven’t had a hearing test in the past year (rising to 88% among those with hearing loss) and 44% are unsure whether their healthcare plan includes hearing coverage. TruHearing launched its “Elect to Reconnect” campaign to drive earlier evaluations and benefit awareness.

Analysis

This reads more like a demand-friction study than a market catalyst. Awareness campaigns can lift inquiries, but the binding constraint in hearing care is usually conversion: coverage verification, out-of-pocket cost, stigma, and the hassle of fitting/trials. That means the immediate market impact is likely negligible; any benefit to device makers or benefit managers would show up only if claims data or provider utilization improves over 1-3 quarters.

The probable winners, if the message lands, are integrated benefit administrators and networked distributors that can reduce friction and steer patients into subsidized channels. The losers are fragmented independent audiology providers and discount retailers that rely on high-touch sales but have weaker financing/coverage navigation. A second-order effect is that more hearing exams can become a lead-generation funnel for broader senior-health services, but only if insurers make the benefit obvious at point of care.

Contrarian view: consensus may overstate the power of “education” and underweight affordability. If seniors already know the issue but still do nothing, the campaign mostly shifts search volume, not revenue. Falsifiers are simple: no rise in hearing-aid claims, no commentary from major MA plans about higher ancillary utilization, or continued low test-to-fit conversion over the next 6-12 months.

Key Decisions for Investors

• No immediate directional trade; treat this as a watch item until we see utilization data, plan-level benefit changes, or earnings commentary from UNH/CVS/ELV on ancillary hearing coverage.
• Conditional pair trade: long UNH or CVS vs XLV only if Medicare Advantage supplemental-benefit utilization trends improve over the next 1-2 quarters; otherwise the signal is too small to underwrite.
• Set an alert for any public evidence of higher hearing-test volume or claim conversion in Ohio/upper-Midwest MA plans; that would be the first real read-through for benefit administrators and device distributors.
• If a liquid public hearing-device proxy is available to us, consider a small starter long only on confirmed conversion metrics, not on awareness headlines alone.